These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16475751)

  • 1. Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm.
    Altschuler MD; Zhu TC; Li J; Hahn SM
    Med Phys; 2005 Dec; 32(12):3524-36. PubMed ID: 16475751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of light sources for prostate photodynamic therapy.
    Altschuler MD; Zhu TC; Li J; Hahn SM
    Proc SPIE Int Soc Opt Eng; 2005 Apr; 5689():186-197. PubMed ID: 26136612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.
    Verigos K; Stripp DC; Mick R; Zhu TC; Whittington R; Smith D; Dimofte A; Finlay J; Busch TM; Tochner ZA; Malkowicz S; Glatstein E; Hahn SM
    J Environ Pathol Toxicol Oncol; 2006; 25(1-2):373-87. PubMed ID: 16566729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.
    Zhu TC; Dimofte A; Finlay JC; Stripp D; Busch T; Miles J; Whittington R; Malkowicz SB; Tochner Z; Glatstein E; Hahn SM
    Photochem Photobiol; 2005; 81(1):96-105. PubMed ID: 15535736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate.
    Li J; Altschuler MD; Hahn SM; Zhu TC
    Phys Med Biol; 2008 Aug; 53(15):4107-21. PubMed ID: 18612172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.
    Zhu TC; Finlay JC; Hahn SM
    J Photochem Photobiol B; 2005 Jun; 79(3):231-41. PubMed ID: 15896650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy in the canine prostate using motexafin lutetium.
    Hsi RA; Kapatkin A; Strandberg J; Zhu T; Vulcan T; Solonenko M; Rodriguez C; Chang J; Saunders M; Mason N; Hahn S
    Clin Cancer Res; 2001 Mar; 7(3):651-60. PubMed ID: 11297261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen.
    Patel H; Mick R; Finlay J; Zhu TC; Rickter E; Cengel KA; Malkowicz SB; Hahn SM; Busch TM
    Clin Cancer Res; 2008 Aug; 14(15):4869-76. PubMed ID: 18676760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy.
    Finlay JC; Zhu TC; Dimofte A; Stripp D; Malkowicz SB; Busch TM; Hahn SM
    Photochem Photobiol; 2006; 82(5):1270-8. PubMed ID: 16808592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer.
    Du KL; Mick R; Busch TM; Zhu TC; Finlay JC; Yu G; Yodh AG; Malkowicz SB; Smith D; Whittington R; Stripp D; Hahn SM
    Lasers Surg Med; 2006 Jun; 38(5):427-34. PubMed ID: 16788929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.
    Zhu TC; Hahn SM; Kapatkin AS; Dimofte A; Rodriguez CE; Vulcan TG; Glatstein E; Hsi RA
    Photochem Photobiol; 2003 Jan; 77(1):81-8. PubMed ID: 12856887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with motexafin lutetium for rectal cancer: a preclinical model in the dog.
    Ross HM; Smelstoys JA; Davis GJ; Kapatkin AS; Del Piero F; Reineke E; Wang H; Zhu TC; Busch TM; Yodh AG; Hahn SM
    J Surg Res; 2006 Oct; 135(2):323-30. PubMed ID: 16650871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterogeneous algorithm for PDT dose optimization for prostate.
    Altschuler MD; Zhu TC; Hu Y; Finlay JC; Dimofte A; Wang K; Li J; Cengel K; Malkowicz SB; Hahn SM
    Proc SPIE Int Soc Opt Eng; 2009 Feb; 7164():71640B. PubMed ID: 25914793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostate.
    Rendon A; Beck JC; Lilge L
    Phys Med Biol; 2008 Feb; 53(4):1131-49. PubMed ID: 18263963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light.
    Yu G; Durduran T; Zhou C; Zhu TC; Finlay JC; Busch TM; Malkowicz SB; Hahn SM; Yodh AG
    Photochem Photobiol; 2006; 82(5):1279-84. PubMed ID: 16696593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate.
    Johansson A; Axelsson J; Andersson-Engels S; Swartling J
    Med Phys; 2007 Nov; 34(11):4309-21. PubMed ID: 18072496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers.
    Chen Q; Huang Z; Luck D; Beckers J; Brun PH; Wilson BC; Scherz A; Salomon Y; Hetzel FW
    Photochem Photobiol; 2002 Oct; 76(4):438-45. PubMed ID: 12405153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer.
    Swartling J; Axelsson J; Ahlgren G; Kälkner KM; Nilsson S; Svanberg S; Svanberg K; Andersson-Engels S
    J Biomed Opt; 2010; 15(5):058003. PubMed ID: 21054129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy for focal ablation of the prostate.
    Arumainayagam N; Moore CM; Ahmed HU; Emberton M
    World J Urol; 2010 Oct; 28(5):571-6. PubMed ID: 20454966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative dynamic dose optimization in permanent prostate implants.
    Lee EK; Zaider M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):854-61. PubMed ID: 12788195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.